Table 3

Response by NHL subtype

HistologyNo. evaluable patients*CR (%)PR (%)OR (%)
MCL 17 13 (76) 3 (18) 16 (94) 
DLCL 16 5† (31) 1† (6) 6 (37) 
FL 10* 5 (50) 4 (40) 9 (90) 
MZL 1 0 1 (100) 1 (100) 
Transformed lymphoma 2 1 (50) 0 1 (50) 
All patients 46* 24 (52) 9 (20) 33 (72) 
HistologyNo. evaluable patients*CR (%)PR (%)OR (%)
MCL 17 13 (76) 3 (18) 16 (94) 
DLCL 16 5† (31) 1† (6) 6 (37) 
FL 10* 5 (50) 4 (40) 9 (90) 
MZL 1 0 1 (100) 1 (100) 
Transformed lymphoma 2 1 (50) 0 1 (50) 
All patients 46* 24 (52) 9 (20) 33 (72) 
*

Two patients with FL and grade 3 rash during cycle 1 were not evaluable.

†

Three patients with DLCL with a CR and 1 patient with a PR had ABC DLCL by the Hans immunohistochemical criteria.14  For the other 2 DLCL patients with a CR, 1 had GCB DLCL, and 1 was unclassifiable.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal